Skip to main content
Article thumbnail
Location of Repository

Cholesterol-Dependent Anaplasma phagocytophilum Exploits the Low-Density Lipoprotein Uptake Pathway

By Qingming Xiong, Mingqun Lin and Yasuko Rikihisa

Abstract

In eukaryotes, intracellular cholesterol homeostasis and trafficking are tightly regulated. Certain bacteria, such as Anaplasma phagocytophilum, also require cholesterol; it is unknown, however, how this cholesterol-dependent obligatory intracellular bacterium of granulocytes interacts with the host cell cholesterol regulatory pathway to acquire cholesterol. Here, we report that total host cell cholesterol increased >2-fold during A. phagocytophilum infection in a human promyelocytic leukemia cell line. Cellular free cholesterol was enriched in A. phagocytophilum inclusions as detected by filipin staining. We determined that A. phagocytophilum requires cholesterol derived from low-density lipoprotein (LDL), because its replication was significantly inhibited by depleting the growth medium of cholesterol-containing lipoproteins, by blocking LDL uptake with a monoclonal antibody against LDL receptor (LDLR), or by treating the host cells with inhibitors that block LDL-derived cholesterol egress from late endosomes or lysosomes. However, de novo cholesterol biosynthesis is not required, since inhibition of the biosynthesis pathway did not inhibit A. phagocytophilum infection. The uptake of fluorescence-labeled LDL was enhanced in infected cells, and LDLR expression was up-regulated at both the mRNA and protein levels. A. phagocytophilum infection stabilized LDLR mRNA through the 3′ UTR region, but not through activation of the sterol regulatory element binding proteins. Extracellular signal–regulated kinase (ERK) was up-regulated by A. phagocytophilum infection, and inhibition of its upstream kinase, MEK, by a specific inhibitor or siRNA knockdown, reduced A. phagocytophilum infection. Up-regulation of LDLR mRNA by A. phagocytophilum was also inhibited by the MEK inhibitor; however, it was unclear whether ERK activation is required for LDLR mRNA up-regulation by A. phagocytophilum. These data reveal that A. phagocytophilum exploits the host LDL uptake pathway and LDLR mRNA regulatory system to accumulate cholesterol in inclusions to facilitate its replication

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:2654415
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (1999). A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood.
    2. (1986). A receptor-mediated pathway for cholesterol homeostasis.
    3. (2004). Activation of Raf/MEK/ERK/cPLA2 signaling pathway is essential for chlamydial acquisition of host glycerophospholipids.
    4. (2007). Anaplasma phagocytophilum AnkA secreted by type IV secretion system is tyrosine phosphorylated by Abl-1 to facilitate infection.
    5. (2004). Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins.
    6. (2000). Caveolins and cellular cholesterol balance.
    7. (2008). Cellular cholesterol trafficking and compartmentalization.
    8. (1998). Characterization of monoclonal antibodies to the 44-kilodalton major outer membrane protein of the human granulocytic ehrlichiosis agent.
    9. (1997). Cholesterol cytochemistry in cell biology and disease.
    10. (1994). Cholesterol homeostasis. Modulation by amphiphiles.
    11. (2006). Cholesterol sensing, trafficking, and esterification.
    12. (1996). Cleavage of sterol regulatory element binding proteins (SREBPs) by CPP32 during apoptosis.
    13. (2002). Consequences of cellular cholesterol accumulation: basic concepts and physiological implications.
    14. (2007). Constitutive and inducible thymic stromal lymphopoietin expression in human airway smooth muscle cells: role in chronic obstructive pulmonary disease.
    15. (2006). Coxiella burnetii inhabits a cholesterol-rich vacuole and influences cellular cholesterol metabolism.
    16. (2008). Cytoplasmic lipid droplets are translocated into the lumen of the Chlamydia trachomatis parasitophorous vacuole.
    17. (2007). Degradation of the LDL receptors by PCSK9 is not mediated by a secreted protein acted upon by PCSK9 extracellularly.
    18. (1996). Determination of LDL- and scavenger-receptor activity in adherent and non-adherent cultured cells with a new single-step fluorometric assay.
    19. (1991). Disposition of intracellular cholesterol in human fibroblasts.
    20. (2003). Ehrlichia chaffeensis and Anaplasma phagocytophilum lack genes for lipid A biosynthesis and incorporate cholesterol for their survival.
    21. (2008). Expression of perilipin in human promyelocytic cells in response to Anaplasma phagocytophilum infection results in modified lipid metabolism.
    22. (2005). Extracellular signal-regulated kinasedependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine.
    23. (2003). Golgi-dependent transport of cholesterol to the Chlamydia trachomatis inclusion.
    24. (2007). High-cholesterol diet facilitates Anaplasma phagocytophilum infection and up-regulates macrophage inflammatory protein2 and CXCR2 expression in apolipoprotein E-deficient mice.
    25. (1999). Human granulocytic ehrlichiosis agent and Ehrlichia chaffeensis reside in different cytoplasmic compartments in HL-60 cells.
    26. (2000). Human granulocytic ehrlichiosis.
    27. (2006). Human low-density lipoprotein receptor gene and its regulation.
    28. (1982). Immunoblot analysis of low density lipoprotein receptors in fibroblasts from subjects with familial hypercholesterolemia.
    29. (2004). Infection of endothelial cells with Anaplasma marginale
    30. (1998). Lack of predictability of classical animal models for hypolipidemic activity: a good time for mice?
    31. (1991). Lipoprotein receptors of HL-60 macrophages. Effect of differentiation with tetramyristic phorbol acetate and 1,25-dihydroxyvitamin D3.
    32. (2002). Macrophage plasma membrane cholesterol contributes to Brucella abortus infection of mice.
    33. (2007). Mechanisms of host cell exit by the intracellular bacterium Chlamydia.
    34. (2005). Membrane cholesterol: a crucial molecule affecting interactions of microbial pathogens with mammalian cells.
    35. (1980). Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.
    36. (2007). Neutrophil granules: a library of innate immunity proteins.
    37. (2000). Niemannpick type C1 (NPC1) overexpression alters cellular cholesterol homeostasis.
    38. (2005). Rambukkana A
    39. (1993). Rapid fluorometric assay of LDL receptor activity by DiI-labeled LDL.
    40. (1995). Role of Ca2+ and calmodulin in ehrlichial infection in macrophages.
    41. (2002). Role of mitogen-activated protein kinases and protein kinase C in regulating low-density lipoprotein receptor expression.
    42. (2004). Salmonella enterica serovar Typhimurium requires nonsterol precursors of the cholesterol biosynthetic pathway for intracellular proliferation.
    43. (2002). SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver.
    44. (1998). Stabilization and cytoskeletalassociation of LDL receptor mRNA are mediated by distinct domains in its 39 untranslated region.
    45. (2001). Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes.
    46. (1960). Studies on the synthesis and secretion of serum lipoproteins by rat liver slices.
    47. (1974). Suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and inhibition of growth of human fibroblasts by 7-ketocholesterol.
    48. (2005). Tabas I
    49. (1997). The fate of cholesterol exiting lysosomes.
    50. (1984). The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA.
    51. (2005). The interactions of Anaplasma phagocytophilum, endothelial cells, and human neutrophils.
    52. (1989). The intracellular transport of low density lipoproteinderived cholesterol is inhibited in Chinese hamster ovary cells cultured with 3-beta-[2-(diethylamino)ethoxy]androst-5-en-17-one.
    53. (2002). The Salmonella pathogenicity island 1 secretion system directs cellular cholesterol redistribution during mammalian cell entry and intracellular trafficking.
    54. (2002). The Salmonella-containing vacuole is a major site of intracellular cholesterol accumulation and recruits the GPI-anchored protein CD55.
    55. (1997). The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor.
    56. (2000). Toxoplasma gondii exploits host lowdensity lipoprotein receptor-mediated endocytosis for cholesterol acquisition.
    57. (1999). Toxoplasma gondii resides in a vacuole that avoids fusion with host cell endocytic and exocytic vesicular trafficking pathways.
    58. (2006). Toxoplasma gondii sequesters lysosomes from mammalian hosts in the vacuolar space.
    59. (2006). Trafficking from CD63-positive late endocytic multivesicular bodies is essential for intracellular development of Chlamydia trachomatis.
    60. (2005). Transcriptional regulation of phagocytosis-induced membrane biogenesis by sterol regulatory element binding proteins.
    61. (1997). Ultrastructural and antigenic characterization of a granulocytic ehrlichiosis agent directly isolated and stably cultivated from a patient in New York state.
    62. (1997). Upregulation of low density lipoprotein receptor by gemfibrozil, a hypolipidemic agent, in human hepatoma cells through stabilization of mRNA transcripts.
    63. (2002). Vesicular and non-vesicular sterol transport in living cells. The endocytic recycling compartment is a major sterol storage organelle.
    64. (1995). VIP21/caveolin is a cholesterol-binding protein.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.